Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking semaglutide experience mild, short-lived gut symptoms that settle on their own. Severe side effects are less common, but they do happen, and knowing which symptoms need urgent attention could matter. This page explains the serious side effects associated with semaglutide, what the clinical evidence tells us about their frequency, and when to get medical help — drawing on the NHS medicines guidance on semaglutide and the MHRA's ongoing safety monitoring. As a prescription-only medicine, semaglutide (sold for weight management as Wegovy) is assessed and prescribed by a clinician who weighs up your medical history before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've been on semaglutide for a few weeks and suddenly develop pain that's different in character from anything before) deep, persistent, and spreading towards your back — that's the moment to stop reading articles and call 111 or go to A&E. What you're describing could be acute pancreatitis, a known side effect of semaglutide that is worth understanding in full before it catches you off guard. In January 2026 the MHRA issued a formal Drug Safety Update reinforcing pancreatitis as an infrequent but potentially serious risk with this class of medicines. "Infrequent" is clinically meaningful: it doesn't mean rare enough to ignore.
Gallbladder disease is a second serious risk. Rapid weight loss itself (regardless of method) increases the odds of gallstone formation, and GLP-1 medicines may add to that through effects on gallbladder motility. The symptom to watch for is sharp or cramping pain under the right ribs or in the upper right abdomen, sometimes spreading to the shoulder. That needs a GP or urgent care assessment, not watchful waiting at home.
If you've had pancreatitis before, or a history of gallbladder problems, your prescriber should know before semaglutide is started. Our overview of Wegovy covers the full eligibility picture, including which medical histories change the risk calculation.
Nausea, loose stools, indigestion, burping, constipation: these are the side effects the vast majority of people encounter, particularly in the first few weeks or after a dose increase. They're uncomfortable. They're also usually short-lived and improve as the body adjusts. You can read a fuller breakdown of how common gut symptoms tend to behave over time on our semaglutide side effects page.
The point where ordinary GI upset becomes a clinical concern is dehydration. If vomiting or diarrhoea is persistent (meaning you cannot keep fluids down for more than a few hours) the kidneys can come under pressure quickly. Signs of significant dehydration include a dry mouth, dizziness on standing, very dark urine, or producing almost none at all. That combination, especially alongside GI symptoms, warrants a call to a healthcare professional the same day. It is not catastrophising; it's the right threshold.
People sometimes wonder whether their experience is typical or a warning sign. The honest answer is that the duration of side effects varies between individuals, which is exactly why prescriber support matters beyond the initial approval stage. It's reasonable to feel uncertain about where the line is, most people on a new medicine do.
The following symptoms require prompt medical attention, not monitoring overnight, not a forum search. Call 999 or attend A&E for chest pain, difficulty breathing, or severe swelling of the face, lips, or throat (possible allergic reaction). Call 111 or your GP urgently for severe and persistent abdominal pain, especially if it radiates to the back; for pain in the upper right abdomen or shoulder that doesn't resolve; for signs of significant dehydration as described above; for yellowing of the skin or whites of the eyes (jaundice, which can indicate a bile duct problem); and for any sudden change in vision if you have diabetes.
Mental health is also worth naming. A small number of people have reported low mood or thoughts of self-harm whilst taking GLP-1 medicines, and our page covering side effects from semaglutide goes into more detail on what to watch for and when to act. If your mood changes in a way that concerns you or someone close to you, speak to your GP or contact Mind for support. It's the kind of thing to mention in your next clinical review rather than sit with quietly.
Any suspected side effect can be reported (by you directly, without going through a doctor) via the MHRA's Yellow Card scheme. Doing so contributes to post-market safety data for these medicines. Worth knowing.
The severe side effects described here are real, but they don't appear out of nowhere. A proper prescribing process involves reviewing your medical history for conditions that raise risk, previous pancreatitis, active gallbladder disease, certain gastrointestinal disorders, thyroid history. That assessment happens before the first dose, not after a problem arises.
At nume, a GPhC-registered Independent Prescriber reads your consultation personally; no algorithm filters your answers and waves you through. Our pharmacy holds GPhC premises registration 9012878, which you can check directly on the GPhC register. Our clinical team also provides aftercare seven days a week, so if something changes after your first pen there is a straightforward route back to a prescriber.
If you have questions about whether semaglutide is appropriate given your medical history (including any previous side effects or concerns about the risks on this page) speak to our prescribers as the first step. They cover suitability and side effects as part of the consultation, not as an afterthought. You can also find broader information on our Wegovy side effects page or explore treatment options to understand what else is available.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.